ASSESSMENT OF THE IL-33/SST2 AXIS IN THE SEROLOGICAL PROFILE OF PSORIASIS PATIENTS

Umit AKPINAR, Gunes Gur AKSOY, Yildiz HAYRAN, Esra Firat OGUZ, Akin AKTAS, Ekrem CIVAS, Berna AKSOY

Journal of Clinical Trials and Experimental Investigations - 2026;5(3):0-0

Private Dermatology Practice Clinic, Ankara, Turkey

 

Objective: Previous studies have reported conflicting findings regarding the role of the IL-33/sST2 axis and circulating IL-33 and sST2 concentrations in psoriasis. This study aimed to evaluate serum IL-33 and sST2 concentrations in patients with psoriasis and controls. Materials and methods: The study included 75 patients with psoriasis and 75 age- and sex-matched controls with non-inflammatory dermatological conditions, all aged 18-65 years. Demographic and clinical characteristics and body mass index (BMI) were recorded, and disease severity was assessed using the Psoriasis Area and Severity Index (PASI). Serum IL-33 and sST2 concentrations were measured using ELISA. Results: Mean serum IL-33 concentrations were significantly lower in patients with psoriasis than in controls (153.9 +/- 59.7 vs. 157.8 +/- 34.4 pg/mL, p = 0.001). Median serum sST2 concentrations did not differ significantly between patients with psoriasis and controls (9.1 vs. 10.6 ng/mL, p = 0.74). IL-33 concentrations showed a positive correlation with age (r = 0.26, p = 0.007), whereas sST2 concentrations were higher in male than in female participants (11.2 vs. 7.8 ng/mL, p = 0.003). Conclusion: Lower circulating IL-33 concentrations were observed in patients with psoriasis, whereas sST2 concentrations did not differ significantly from those in controls. These findings suggest that circulating IL-33 may not directly reflect its local activity in psoriatic tissue. Tissue-specific regulation or limited systemic release may contribute to this discrepancy, although this hypothesis requires further investigation.